UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of September 2020
Commission File Number: 001-39481
PainReform Ltd.
(Translation of registrant’s name into English)
60C Medinat Hayehudim
Herzliya, 4676670
Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
PainReform Ltd
Explanatory Note
The following exhibits are attached:
99.1 Unaudited Condensed Financial Statements as of June 30, 2020
99.2 Operating and Financial Review and Prospects as of June 30, 2020
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PAINREFORM LTD. | ||
Date: September 30, 2020 | By: | /s/ Eli Hazum |
Eli Hazum | ||
Chief Executive Officer |
2
Exhibit Index
Exhibit No. | Description | |
99.1 | Unaudited Interim Condensed Consolidated Financial Statements as of June 30, 2020 | |
99.2 | Operating and Financial Review and Prospects as of June 30, 2020 |
3